Fecal transplants for autism deliver success in clinical trials

Clinical trials suggest fecal microbiota transplants may help some autistic children by improving gut health and easing certain symptoms.

The discussion focused on possible microbiome and gut-brain axis mechanisms, as well as the role of diet in shaping outcomes.

Commenters also noted that researchers patented a bacterial formulation and formed Gut-Brain Axis Therapeutics to commercialize the approach.

The findings point to a possible new autism therapy, but questions remain about long-term effects, evidence quality, and scalability.